Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Rioth · SciRah

Researcher profile · Semantic Scholar

M. Rioth

Share profile

M. Rioth — researcher profile on SciRah

h-index: 17
Works: 63
Citations: 1,738

Most-cited papers

Targeted next generation sequencing identifies markers of response to PD-1 blockade
Douglas B. Johnson, G. Frampton, M. Rioth, E. Yusko +23 more
2016Cancer immunology research425 citations Open access
Semantic Scholar
Report TORC1 Is Essential for NF1-Associated Malignancies
C. Johannessen, Bryan W. Johnson, Sybil M. Genther Williams, A. Chan +7 more
2008210 citations
Semantic Scholar
Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch
S. Giuriato, S. Ryeom, Alice C. Fan, Pavan Bachireddy +8 more
2006Proceedings of the National Academy of Sciences of the United States of America163 citations Open access
Semantic Scholar
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial
R. Carvajal, M. Butler, A. Shoushtari, J. Hassel +17 more
2022Nature Medicine153 citations Open access
Semantic Scholar
Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth.
S. Ryeom, Kwan-Hyuck Baek, M. Rioth, R. Lynch +4 more
2008Cancer Cell132 citations Open access
Semantic Scholar
Immune Checkpoint Inhibitors in NSCLC
Douglas B. Johnson, M. Rioth, L. Horn
2014Current Treatment Options in Oncology79 citations Open access
Semantic Scholar
Integrated Biomarkers for the Management of Indeterminate Pulmonary Nodules.
M. Kammer, D. Lakhani, A. Balar, S. Antic +35 more
2021American Journal of Respiratory and Critical Care Medicine63 citations Open access
Semantic Scholar
SMART precision cancer medicine: a FHIR-based app to provide genomic information at the point of care
J. Warner, M. Rioth, K. Mandl, J. Mandel +8 more
2016J. Am. Medical Informatics Assoc.62 citations Open access
Semantic Scholar
Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium
P. Beaudry, M. Nilsson, M. Rioth, D. Prox +7 more
2008Molecular Cancer Therapeutics53 citations Open access
Semantic Scholar
ALK inhibitor response in melanomas expressing EML4-ALK fusions and alternate ALK isoforms
K. Couts, Judson G. T. Bemis, Jacqueline A. Turner, S. Bagby +18 more
2017Molecular Cancer Therapeutics51 citations Open access
Semantic Scholar
Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experience
C. Aquilante, David P. Kao, Katy E. Trinkley, Chen-Tan Lin +15 more
2020Pharmacogenomics (London)47 citations Open access
Semantic Scholar
Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy
C. Amato, Jennifer D. Hintzsche, K. Wells, Allison Applegate +13 more
2020Cancers47 citations Open access
Semantic Scholar
A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma
M. Hasanov, M. Rioth, K. Kendra, L. Hernandez-Aya +10 more
2020Cancers36 citations Open access
Semantic Scholar
64MO A phase (ph) II, multi-center study of the safety and efficacy of tebentafusp (tebe) (IMCgp100) in patients (pts) with metastatic uveal melanoma (mUM)
J. Sacco, R. Carvajal, M. Butler, A. Shoushtari +15 more
202032 citations Open access
Semantic Scholar
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma
J. J. Sacco, R. Carvajal, M. O. Butler, A. Shoushtari +14 more
2024Journal for ImmunoTherapy of Cancer27 citations Open access
Semantic Scholar
A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making
C. Friedman, Madison Lyon, R. Torphy, Daniel T. Thieu +9 more
2019Journal of Surgical Oncology26 citations
Semantic Scholar
Validation of a Mortality Composite Score in the Real-World Setting: Overcoming Source-Specific Disparities and Biases
M. Lerman, Benjamin Holmes, D. S. St. Hilaire, Mary Tran +4 more
2021JCO Clinical Cancer Informatics17 citations Open access
Semantic Scholar
Next generation long term transplant clinics: Improving resource utilization and the quality of care through health information technology
M. Rioth, Jeremy L. Warner, B. Savani, M. Jagasia
2015Bone Marrow Transplantation16 citations Open access
Semantic Scholar
Hybrid capture-based next-generation sequencing (HC NGS) in melanoma to identify markers of response to anti-PD-1/PD-L1.
Douglas B. Johnson, G. Frampton, M. Rioth, E. Yusko +15 more
201615 citations
Semantic Scholar
Customizable Natural Language Processing Biomarker Extraction Tool.
Benjamin Holmes, D. Chitale, J. Loving, Mary Tran +5 more
2021JCO Clinical Cancer Informatics14 citations Open access
Semantic Scholar
Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment
M. Hawkins, M. Rioth, Megan M Eguchi, M. Cockburn
2019Journal of American Academy of Dermatology12 citations Open access
Semantic Scholar
Change Management for the Successful Adoption of Clinical Information Systems
Christoph U. Lehmann, K. Unertl, M. Rioth, N. Lorenzi
201612 citations
Semantic Scholar
Implementing Real-World RECIST-based Tumor Response Assessment in Patients With Metastatic Non-small Cell Lung Cancer.
M. Izano, Nguyet Tran, A. Fu, Liz Toland +7 more
2022Clinical Lung Cancer11 citations
Semantic Scholar
Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling
Jacqueline A. Turner, Robert J. Van Gulick, William A. Robinson, Tariq I. Mughal +23 more
2024International Journal of Cancer8 citations Open access
Semantic Scholar
Characterization of cytokine release syndrome (CRS) following treatment with tebentafusp in patients (pts) with previously treated (2L+) metastatic uveal melanoma (mUM).
R. Carvajal, Takami Sato, M. Butler, J. Sacco +16 more
20216 citations
Semantic Scholar
Advances in website information resources to aid in clinical practice.
M. Rioth, Travis J. Osterman, J. Warner
2015American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting5 citations
Semantic Scholar
Pragmatic precision oncology: the secondary uses of clinical tumor molecular profiling
M. Rioth, R. Thota, David B. Staggs, Douglas B. Johnson +1 more
2016J. Am. Medical Informatics Assoc.4 citations Open access
Semantic Scholar
Machine learning application to find patients with lower-risk myelodysplastic syndrome from real-world data.
C. Johanson, Hu T. Huang, D. Idryo, R. Broome +2 more
2022Journal of Clinical Oncology3 citations
Semantic Scholar
538 Updated survival of patients with previously treated metastatic uveal melanoma who received tebentafusp
J. Sacco, R. Carvajal, Marcus Butler, A. Shoushtari +15 more
2021Journal for ImmunoTherapy of Cancer3 citations Open access
Semantic Scholar
Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis
Xuan-Yi Li, E. Sigworth, Adrianne H. Wu, J. Behrens +29 more
2019Scientific Reports3 citations Open access
Semantic Scholar
Implementing and Improving Automated Electronic Tumor Molecular Profiling.
M. Rioth, David B. Staggs, Lauren Hackett, E. Haberman +3 more
2016Journal of Oncology Practice2 citations Open access
Semantic Scholar
843P Long-term survivors on tebentafusp in phase II trial of previously treated patients with metastatic uveal melanoma
T. Sato, A. Ikeguchi, P. Nathan, R. Carvajal +16 more
2022Annals of Oncology1 citations Open access
Semantic Scholar
Rapid adoption of immunotherapy in community health systems, associated with changing treatment guidelines.
Alissa Winzeler-Cotton, Akila Subramanian, K. Kane, Chenan Zhang +3 more
2022Journal of Clinical Oncology1 citations
Semantic Scholar
Characterization of liver function tests (LFTs) following tebentafusp (tebe) in previously treated (2L+) metastatic uveal melanoma (mUM) patients (pts).
Takami Sato, R. Carvajal, J. Sacco, A. Shoushtari +16 more
20211 citations
Semantic Scholar
Disparities in patient portal messaging by hematology and oncology patients.
M. Rioth, R. Cronin, Sharon E. Davis, G. Jackson
20151 citations
Semantic Scholar
Improvements in screening precision with AI-enhanced clinical trial matching using EMR source data for cancer clinical trials.
Adam Petranovich, Irene Barcelon, Caroline Bennette, D. Connolly +8 more
2025JCO Oncology Practice0 citations
Semantic Scholar
Abstract CT223: Long-term survival follow-up of tebentafusp in previously treated metastatic uveal melanoma (mUM)
J. Sacco, R. Carvajal, M. Butler, A. Shoushtari +15 more
2023Cancer Research0 citations
Semantic Scholar
RWD55 Predicting Metastatic Disease Progression in Prostate Cancer Patients Using Machine Learning of PSA Kinetics
R. Lorenzo, F. Green, M. Rioth, J. Loving
2023Value in Health0 citations
Semantic Scholar
Sequential learning for pan-tumor detection of metastatic disease progression.
Foad Green, M. Rioth, J. Loving
2023Journal of Clinical Oncology0 citations Open access
Semantic Scholar
POSC408 Demographic Characteristics and Initial Diagnostic Staging of Patients with Non-Small Cell Lung Cancer across Large Community Health Systems in the US
R. Lorenzo, D. Pomerantz, V. Subramanian, M. Tran +8 more
2022Value in Health0 citations Open access
Semantic Scholar
Using machine learning on real-world data to predict metastatic status.
Foad Green, Hu T. Huang, M. Lerman, Mary Tran +3 more
2022Journal of Clinical Oncology0 citations
Semantic Scholar
RWD82 Systemic Antineoplastic Treatment Utilization Among Patients with Advanced Colorectal Cancer across Large Community Health Systems in the US
R. Lorenzo, D. Pomerantz, F. Wolf, C. Sommers +5 more
2022Value in Health0 citations Open access
Semantic Scholar
RWD56 Demographic Characteristics and Initial Diagnostic Staging of Patients with Prostate Cancer across Large Community Health Systems in the US
R. Lorenzo, D. Pomerantz, F. Wolf, T. Brown +4 more
2022Value in Health0 citations Open access
Semantic Scholar
RWD139 Demographic Characteristics and Initial Diagnostic Staging of Patients with Triple Negative Breast Cancer across Large Community Health Systems in the US
R. Lorenzo, D. Pomerantz, F. Wolf, C. Sommers +5 more
2022Value in Health0 citations Open access
Semantic Scholar
RWD110 Demographic Characteristics and Initial Diagnostic Staging of Patients with Ovarian Cancer across Large Community Health Systems in the US
R. Lorenzo, D. Pomerantz, F. Wolf, C. Sommers +5 more
2022Value in Health0 citations Open access
Semantic Scholar
RWD109 Systemic Antineoplastic Treatment Utilization Among Patients with Advanced HER2+ Breast Cancer across Large Community Health Systems in the US
R. Lorenzo, D. Pomerantz, F. Wolf, C. Sommers +5 more
2022Value in Health0 citations Open access
Semantic Scholar
POSB413 Demographic Characteristics and Disease Subtypes of Patients with Acute Myeloid Leukemia across Large Community Health Systems in the US
R. Lorenzo, D. Pomerantz, V. Subramanian, M. Tran +8 more
2022Value in Health0 citations Open access
Semantic Scholar
POSA409 Somatic Gene Alteration Testing and Systemic Antineoplastic Treatment Utilization Among Patients with Advanced Non-Small Cell Lung Cancer across Large Community Health Systems in the US
R. Lorenzo, D. Pomerantz, V. Subramanian, M. Tran +8 more
2022Value in Health0 citations Open access
Semantic Scholar
RWD118 Rapid Diversification of Immune Checkpoint Inhibitor Usage in Community Health Systems in the US Following New Drug Approvals
A. Winzeler, K. Kane, C. Zhang, A. Subramanian +3 more
2022Value in Health0 citations Open access
Semantic Scholar
RWD55 Systemic Antineoplastic Treatment Utilization Among Patients with Advanced Triple Negative Breast Cancer across Large Community Health Systems in the US
R. Lorenzo, D. Pomerantz, F. Wolf, C. Sommers +5 more
2022Value in Health0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Douglas B. Johnson×10
Invite
Douglas B. Johnson — researcher profile on SciRah
R. Lorenzo×10
Invite
R. Lorenzo — researcher profile on SciRah
L. Hernandez-Aya×9
Invite
L. Hernandez-Aya — researcher profile on SciRah
F. Wolf×9
Invite
F. Wolf — researcher profile on SciRah

×9

Invite

T. Brown — researcher profile on SciRah

A. Shoushtari×8

Invite

A. Shoushtari — researcher profile on SciRah

Invite

A. Ikeguchi — researcher profile on SciRah

Invite

M. Lerman — researcher profile on SciRah

Invite

T. Wolfe — researcher profile on SciRah

Invite

J. Hassel — researcher profile on SciRah

Invite

P. Nathan — researcher profile on SciRah

Invite

S. Leyvraz — researcher profile on SciRah